DEAN J. MITCHELL - 16 Jun 2021 Form 4 Insider Report for ImmunoGen, Inc.

Role
Director
Signature
/s/ Joseph J. Kenny, attorney in fact
Issuer symbol
N/A
Transactions as of
16 Jun 2021
Net transactions value
+$297,880
Form type
4
Filing time
17 Jun 2021, 16:21:41 UTC
Previous filing
14 Jun 2021
Next filing
02 Jul 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMGN Deferred Share Unit Award $0 +15,000 +16% $0.000000 108,774 16 Jun 2021 Common Stock 15,000 $0.000000 Direct F1, F2, F3
transaction IMGN Stock Option (right to buy) Award $297,880 +44,000 $6.77 44,000 16 Jun 2021 Common Stock 44,000 $6.77 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The deferred share units were issued pursuant to the Issuer's Compensation Policy for Non-Employee Directors and are convertible into Common Stock on a one-to-one basis.
F2 The vested deferred share units are to be settled 100% in shares of Common Stock of the Company upon the reporting person's retirement from the Board of Directors.
F3 The deferred share units vest quarterly on each of 9/1/21, 12/1/21, 3/1/22, and 6/1/22, contingent upon the individual remaining a director as of each vesting date.
F4 Exercisable as to 11,000 shares on each of 9/1/21, 12/1/21, 3/1/22, and 6/1/22, contingent upon the individual remaining a director as of each vesting date.